...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Holy Grail treatment for COVID-19 remains out of reach. But options exist

Wonder if the Canadian professor even knows that we exist? Gotta love that WHO position, so will Resverlogix wait for his call...or make the call themselves?

Holy Grail? Could we be talking apabetalone if the numbers are as good as Don teased?

 

Dr. Srinivas Murthy, an infectious disease physician and a clinical associate professor in pediatrics at the University of British Columbia in Vancouver, said a treatment that's simple and works to prevent COVID-19 from becoming severe is "the Holy Grail right now."

"The challenge with any of those treatments is that you have to give it to a lot of people to prevent hospitalizations or severe disease because a lot of people have mild-COVID," Murthy said. "Whatever you give has to be safe and convenient otherwise people won't take it."

 

 

UBC's Murthy, who also co-chairs the World Health Organization's clinical research committee on COVID-19, said monoclonal antibodies haven't really been embraced in Canada yet because of access and feasibility questions.

To conduct the trial in southern California for instance, Khan's hospital set up a special tent outside, similar to COVID assessment centres at some Canadian hospitals. The site is staffed by health-care workers wearing full personal protective equipment to minimize the risk of people coming to participate in the trial spreading COVID-19 to any patients or staff.

https://www.cbc.ca/news/health/monoclonal-antibodies-covid-yearender-1.5853169

Share
New Message
Please login to post a reply